In recent years, the stent technology available for endovascular treatment of aortic dissections has advanced tremendously. It is now possible to apply this minimally invasive technique to a wider range of pathology. The aim of this study was to develop anti-thrombogenic coronary stent using ion-beam technology. Our previous study indicted that He + -irradiated collagen surface with a fluence of 1 10 14 ions/cm 2 has excellent antithrombogenicity and cell attachment property.
Summary:
In recent years, the stent technology available for endovascular treatment of aortic dissections has advanced tremendously. It is now possible to apply this minimally invasive technique to a wider range of pathology. The aim of this study was to develop anti-thrombogenic coronary stent using ion-beam technology. Our previous study indicted that He + -irradiated collagen surface with a fluence of 1 10 14 ions/cm 2 has excellent antithrombogenicity and cell attachment property.
The ion beam irradiated collagen-coated Ni-Ti and available SUS stents demonstrated a high antithrombogenicity and endothelialization in animal studies. The implantation of ions into a collagencoated surface is a promising approach for developing a new stent. It is therefore very likely that ion-implanted collagen-coated stents will be clinically applicable. 
